Clinical Trial Update: Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing aprepitant to gabapentin for the prevention of delayed nausea and vomiting in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aprepitant (aprepitant)
• Gabapentin (Gabapentin)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Cancer | Phase 2 | Status: COMPLETED